Title : NCOA4-RET fusion in colorectal cancer: Therapeutic challenge using patient-derived tumor cell lines.

Pub. Date : 2018

PMID : 30210625






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In colon cancer PDCs with NCOA4-RET fusion, vandetanib potently inhibited AKT and ERK phosphorylation. vandetanib nuclear receptor coactivator 4 Homo sapiens
2 This study shows that vandetanib might be one of useful treatment strategies for CRC patient with NCOA4-RET fusion. vandetanib nuclear receptor coactivator 4 Homo sapiens